Nektar Therapeutics Promotes Chief Accounting Officer Jillian Thomsen To CFO

(RTTNews) – Nektar Therapeutics (NKTR) introduced Friday the promotion of Jillian Thomsen to Senior Vice President (SVP) & Chief Economical Officer. Thomsen has served as SVP, Finance & Chief Accounting Officer of Nektar considering the fact that 2008, and is a critical member of the Executive Committee.

Gil Labrucherie, the firm’s current Chief Functioning Officer & Main Fiscal Officer, will be departing the organization to go after another chance at a private biotechnology enterprise.

In April 2008, Thomsen was appointed Main Accounting Officer at Nektar and joined the Executive Committee. She has over 30 several years of finance and accounting working experience.

In her latest function, Thomsen oversees accounting, money reporting, FP&A, Sarbanes-Oxley compliance, treasury, tax, scientific outsourcing, and procurement functions at the corporation. From 2006 to 2008, she served as Vice President, Finance and Controller of Nektar.

Prior to becoming a member of Nektar in 2006, Thomsen was Deputy Controller of Calpine Corp. from September 2002 to February 2006.

The views and thoughts expressed herein are the sights and opinions of the author and do not essentially reflect all those of Nasdaq, Inc.

Supply website link